Patents by Inventor Kent W. Hunter

Kent W. Hunter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100166707
    Abstract: Disclosed are methods involving the administration of an extracellular matrix (ECM)/metastasis modifier gene, e.g., Anakin, Necdin, CentaurinD3 (CentD3), Csf1r, Brd4, Pi16, and Luc7l, for the prevention or inhibition of metastasis or of tumor growth. Further disclosed are methods of characterizing a tumor or cancer in a subject comprising detecting (i) a single nucleotide polymorphism (SNP) in an Anakin gene or a Brd4 gene of the subject, (ii) an amino acid substitution in an Anakin protein in the subject, or (iii) a level of expression of an Anakin gene or a Brd4 gene in the subject. Methods of screening a compound for anti-cancer activity and use of a compound with anti-cancer activity for the preparation of a medicament to treat or prevent cancer in a subject are also disclosed. Also disclosed is a method of inhibiting Sipa-1 in a subject.
    Type: Application
    Filed: February 23, 2007
    Publication date: July 1, 2010
    Applicants: GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRES, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Kent W. Hunter, Nigel Crawford, Douglas R. Lowy, Xiaolan Qian, Hoda Anton-Culver, Agryrios Ziogas